The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and the U.K. have already cleared it for use.

While Bayer Leverkusen's pre-season takes them across the Atlantic to the buzzing streets of Rio de Janeiro, their new 2025/26 away shirt takes things back to the heart of home. Presented at the start ...

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German company said on Friday.